drugset / Trial / NCT05020444
TriPRIL CAR T Cells in Multiple Myeloma
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This research study involves the study of TriPRIL CAR T Cells for treating people with relapsed or refractory multiple myeloma and to understand the side effects when treated with TriPRIL CAR T Cells. This research study involves the study drugs:. * TriPRIL CAR T Cells * Fludarabine and Cyclophosphamide: Standardly used chemotherapy drugs as part of lymphodepleting process
Timeline
- Start
- 2021-10-05
- Primary completion
- 2028-02-24
- Completion
- 2028-02-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TriPRIL CAR T Cells | Cell therapy | — | Intravenous |
| Background | Cyclophosphamide | Other / unclassified | — | Intravenous |
| Background | Fludarabine | Small molecule | — | Intravenous |